同步采集的PET与ASL影像生物标志物有助于鉴别治疗后胶质瘤的进展与假性进展
结果显示肿瘤等值线图与T图分析在鉴别进展与假性进展方面具有高特异度和敏感度,尤其对胶质母细胞瘤敏感度最高。
要点
- 同步PET/MR采集的ASL灌注与[18F]DOPA代谢图可联合用于鉴别胶质瘤进展与假性进展。
- 肿瘤等值线图分析在ASL中特异度达100%,[18F]DOPA分析敏感度达94.1%。
- 对胶质母细胞瘤,定性SPM图及半定量rCBF、rSUV分析的敏感度最高。
局限性
- 研究仅纳入单侧治疗后胶质瘤患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this work was investigating the methods based on coupling cerebral perfusion (ASL) and amino acid metabolism ([18F]DOPA-PET) measurements to evaluate the diagnostic performance of PET/MRI in glioma follow-up.
METHODS: Images were acquired using a 3-T PET/MR system, on a prospective cohort of patients addressed for possible glioma progression. Data were preprocessed with statistical parametric mapping (SPM), including registration on T1-weighted images, spatial and intensity normalization, and tumor segmentation. As index tests, tumor isocontour maps of [18F]DOPA-PET and ASL T-maps were created and metabolic/perfusion abnormalities were evaluated with the asymmetry index z-score. SPM map analysis of significant size clusters and semi-quantitative PET and ASL map evaluation were performed and compared to the gold standard diagnosis. Lastly, ASL and PET topography of significant clusters was compared to that of the initial tumor.
RESULTS: Fifty-eight patients with unilateral treated glioma were included (34 progressions and 24 pseudo-progressions). The tumor isocontour maps and T-maps showed the highest specificity (100%) and sensitivity (94.1%) for ASL and [18F]DOPA analysis, respectively. The sensitivity of qualitative SPM maps and semi-quantitative rCBF and rSUV analyses were the highest for glioblastoma.
CONCLUSION: Tumor isocontour T-maps and combined analysis of CBF and [18F]DOPA-PET uptake allow achieving high diagnostic performance in differentiating between progression and pseudo-progression in treated gliomas. The sensitivity is particularly high for glioblastomas.
KEY POINTS: • Applied separately, MRI and PET imaging modalities may be insufficient to characterize the brain glioma post-therapeutic profile. • Combined ASL and [18F]DOPA-PET map analysis allows differentiating between tumor progression and pseudo-progression.
引用
- Pellerin A, Khalifé M, Sanson M, et al. Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudo-progression in treated gliomas. Eur Radiol. 2021. PMID: 33787971. doi:10.1007/s00330-021-07732-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。